James Rolke Insider Trading $LJPC LA JOLLA PHARMACEUTICAL CO
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James Rolke.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James Rolke. James Rolke is Chief Scientific Officer in LA JOLLA PHARMACEUTICAL CO ($LJPC).
James Rolke in LA JOLLA PHARMACEUTICAL CO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James Rolke: Chief Scientific Officer
Holdings: 81,771 shares
Current Value: $1,592,081
Latest Transaction: Jun 02 2020
$LJPC Market Capitalization: $355.22M
$LJPC Previous Close: $19.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James Rolke in LA JOLLA PHARMACEUTICAL CO
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 4.72 | 205 | 968 | 205 | |
| Jun 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 4.01 | 205 | 822 | 81,771 | 81.6 K to 81.8 K (+0.25 %) |
| May 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.89 | 140 | 965 | 140 | |
| May 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.86 | 140 | 820 | 81,566 | 81.4 K to 81.6 K (+0.17 %) |
| May 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.26 | 133 | 966 | 133 | |
| May 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.17 | 133 | 821 | 81,426 | 81.3 K to 81.4 K (+0.16 %) |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.60 | 146 | 964 | 146 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.61 | 146 | 819 | 81,293 | 81.1 K to 81.3 K (+0.18 %) |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 4.20 | 229 | 962 | 229 | |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 3.57 | 229 | 818 | 81,147 | 80.9 K to 81.1 K (+0.28 %) |
| Mar 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 4.00 | 241 | 964 | 241 | |
| Mar 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 3.40 | 241 | 819 | 80,918 | 80.7 K to 80.9 K (+0.30 %) |
| Mar 03 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.80 | 142 | 966 | 142 | |
| Mar 03 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.78 | 142 | 821 | 80,677 | 80.5 K to 80.7 K (+0.18 %) |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.40 | 115 | 966 | 115 | |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.14 | 115 | 821 | 80,535 | 80.4 K to 80.5 K (+0.14 %) |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.85 | 141 | 966 | 141 | |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.82 | 141 | 821 | 80,420 | 80.3 K to 80.4 K (+0.18 %) |
| Jan 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.88 | 692 | 5,453 | 692 | |
| Jan 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.70 | 692 | 4,636 | 80,279 | 79.6 K to 80.3 K (+0.87 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.02 | 118 | 710 | 118 | |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.12 | 118 | 604 | 79,587 | 79.5 K to 79.6 K (+0.15 %) |
| Nov 05 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.02 | 133 | 934 | 133 | |
| Nov 05 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.96 | 133 | 793 | 79,469 | 79.3 K to 79.5 K (+0.17 %) |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.38 | 112 | 939 | 112 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.12 | 112 | 797 | 79,336 | 79.2 K to 79.3 K (+0.14 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.80 | 107 | 942 | 107 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.48 | 107 | 800 | 79,224 | 79.1 K to 79.2 K (+0.14 %) |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 10.92 | 85 | 928 | 85 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 9.28 | 85 | 789 | 79,117 | 79 K to 79.1 K (+0.11 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.57 | 98 | 938 | 98 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.13 | 98 | 797 | 79,032 | 78.9 K to 79 K (+0.12 %) |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.43 | 99 | 934 | 99 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.02 | 99 | 794 | 78,934 | 78.8 K to 78.9 K (+0.13 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.36 | 112 | 936 | 112 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.11 | 112 | 796 | 78,835 | 78.7 K to 78.8 K (+0.14 %) |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.24 | 102 | 942 | 102 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.85 | 102 | 801 | 78,723 | 78.6 K to 78.7 K (+0.13 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.25 | 101 | 934 | 101 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.86 | 101 | 794 | 78,621 | 78.5 K to 78.6 K (+0.13 %) |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.71 | 96 | 932 | 96 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.25 | 96 | 792 | 78,520 | 78.4 K to 78.5 K (+0.12 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 5.39 | 174 | 938 | 174 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 4.58 | 174 | 797 | 78,424 | 78.3 K to 78.4 K (+0.22 %) |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.05 | 116 | 934 | 116 | |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.84 | 116 | 793 | 78,107 | 78 K to 78.1 K (+0.15 %) |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.16 | 131 | 938 | 131 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.09 | 131 | 798 | 77,991 | 77.9 K to 78 K (+0.17 %) |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.43 | 146 | 939 | 146 | |
| Apr 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.47 | 146 | 799 | 77,860 | 77.7 K to 77.9 K (+0.19 %) |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.64 | 122 | 932 | 122 | |
| Mar 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.49 | 122 | 792 | 77,714 | 77.6 K to 77.7 K (+0.16 %) |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 5.70 | 164 | 935 | 164 | |
| Mar 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 4.85 | 164 | 795 | 77,592 | 77.4 K to 77.6 K (+0.21 %) |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.23 | 151 | 941 | 151 | |
| Feb 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.30 | 151 | 800 | 77,428 | 77.3 K to 77.4 K (+0.20 %) |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.04 | 155 | 936 | 155 | |
| Feb 04 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.13 | 155 | 795 | 77,277 | 77.1 K to 77.3 K (+0.20 %) |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 5.99 | 53,000 | 317,470 | 53,000 | |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.75 | 792 | 5,346 | 792 | |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.74 | 792 | 4,546 | 77,122 | 76.3 K to 77.1 K (+1.04 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.10 | 800 | 4,880 | 76,330 | 75.5 K to 76.3 K (+1.06 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.09 | 500 | 3,045 | 75,530 | 75 K to 75.5 K (+0.67 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.07 | 300 | 1,821 | 75,030 | 74.7 K to 75 K (+0.40 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.10 | 800 | 4,880 | 76,330 | 75.5 K to 76.3 K (+1.06 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.09 | 500 | 3,045 | 75,530 | 75 K to 75.5 K (+0.67 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.07 | 300 | 1,821 | 75,030 | 74.7 K to 75 K (+0.40 %) |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.43 | 97 | 915 | 97 | |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.02 | 97 | 778 | 74,730 | 74.6 K to 74.7 K (+0.13 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 12.80 | 70 | 896 | 70 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 12.80 | 70 | 896 | 70 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 10.88 | 70 | 762 | 74,633 | 74.6 K to 74.6 K (+0.09 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 10.88 | 70 | 762 | 74,633 | 74.6 K to 74.6 K (+0.09 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 14.47 | 63 | 912 | 63 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 14.47 | 63 | 912 | 63 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 12.30 | 63 | 775 | 74,563 | 74.5 K to 74.6 K (+0.08 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 12.30 | 63 | 775 | 74,563 | 74.5 K to 74.6 K (+0.08 %) |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 14.90 | 61 | 909 | 61 | |
| Nov 19 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 12.67 | 61 | 773 | 74,500 | 74.4 K to 74.5 K (+0.08 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.30 | 56 | 913 | 56 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.30 | 56 | 913 | 56 | |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.86 | 56 | 776 | 74,439 | 74.4 K to 74.4 K (+0.08 %) |
| Nov 01 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.86 | 56 | 776 | 74,439 | 74.4 K to 74.4 K (+0.08 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.25 | 55 | 894 | 55 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.25 | 55 | 894 | 55 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.81 | 55 | 760 | 74,383 | 74.3 K to 74.4 K (+0.07 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.81 | 55 | 760 | 74,383 | 74.3 K to 74.4 K (+0.07 %) |
| Aug 20 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 22.00 | 1,000 | 21,997 | 74,328 | 73.3 K to 74.3 K (+1.36 %) |
| Aug 20 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 22.00 | 1,000 | 21,997 | 74,328 | 73.3 K to 74.3 K (+1.36 %) |
| Dec 29 2017 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 32.47 | 6,700 | 217,549 | 6,700 | |
| Dec 13 2017 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 28.10 | 49,000 | 1,376,900 | 49,000 | |
| Jan 06 2017 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 19.19 | 64,100 | 1,230,079 | 64,100 |
Page: 1